![Naratriptan icorandil 4-dichlorophenyl)methyl]amino]-adenosine](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M9317_1621560024.gif?v=1621560025)
Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
4-dichlorophenyl)methyl]amino]-adenosine
Smiles: N[C@@H](CC1C=CC=CC=1)C(=O)N1C/C(=C\C2=CC(Cl)=C(Cl)C=C2)/C(=O)/C(/C1)=C/C1=CC(Cl)=C(Cl)C=C1
Molecular Weight: 255
InChi: InChI=1S/C25H33N7O2/c1-2-3-12-27-25-29-16-22(23(31-25)30-19-6-10-21(33)11-7-19)24(34)28-15-18-4-8-20(9-5-18)32-14-13-26-17-32/h4-5
Naratriptan icorandil 4-dichlorophenyl)methyl]amino]-adenosineNaratriptan is a selective 5 HT1 receptor subtype agonist for the treatment of migraine headache. Naratriptan binds with high affinity to human cloned 5 HT1B 1D receptors. Migraines are likely due to local cranial vasodilatation and or to the release of sensory neuropeptides (including substance P and calcitonin gene related peptide) through nerve endings in the trigeminal system. The therapeutic activity of AMERGE for the treatment of migraine
US$ 109.00
US$ 173.00
US$ 110.00
US$ 39.00